Open Orphan Q&A with CEO Cathal Friel (LON:ORPH)
11 March 2020
Bicara Therapeutics Inc. (NASDAQ: BCAX) has been attracting significant attention from investors, particularly those with a keen eye on the biotechnology sector. With a market capitalization of $1.01 billion, this..
Stoke Therapeutics, Inc. (NASDAQ: STOK) has emerged as a formidable contender in the biotechnology sector, captivating investor interest with its promising pipeline of treatments for severe genetic diseases. The company’s..
Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a dynamic player in the healthcare sector, has piqued the interest of investors with its impressive potential upside of 79.87%. Specializing in treatments for rare..
In the ever-dynamic world of biotechnology, Xencor, Inc. (NASDAQ: XNCR) stands out as a promising player with a diverse pipeline of innovative therapies targeting cancer and autoimmune diseases. With a..
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a key player in the biotechnology sector, stands out with its focus on developing genetic therapies for rare and life-threatening diseases. Headquartered in Cranbury, New..
Enhabit, Inc. (NASDAQ: EHAB), a notable player in the healthcare sector specializing in home health and hospice services, has captured investor attention with its remarkable stock performance over the past..
STAAR Surgical Company (NASDAQ: STAA) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $916.73 million, STAAR Surgical..
Zymeworks Inc. (NASDAQ: ZYME) stands out in the biotechnology sector with its innovative approach to developing biotherapeutics for cancer and autoimmune diseases. With a market capitalization of $1.89 billion, this..
For investors navigating the competitive landscape of the healthcare sector, AxoGen, Inc. (NASDAQ: AXGN) presents an intriguing opportunity. Specializing in the niche field of peripheral nerve regeneration and repair, AxoGen..
CareDx, Inc. (NASDAQ: CDNA) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of approximately $998.01 million, the company is..
For individual investors with an eye on the healthcare sector, Avadel Pharmaceuticals plc (NASDAQ: AVDL) represents a compelling case study in the biopharmaceutical space. With its headquarters in Dublin, Ireland,..
Investors with an eye on the biotechnology sector might find Replimune Group, Inc. (NASDAQ: REPL) to be an intriguing opportunity. Headquartered in Woburn, Massachusetts, Replimune is a clinical-stage biotech company..
Iovance Biotherapeutics, Inc. (IOVA) has been making waves in the biotechnology sector, capturing the attention of investors with an impressive potential upside of 96.51%. With a market cap of $1.89..
Akebia Therapeutics, Inc. (NASDAQ: AKBA) has emerged as a compelling player in the healthcare sector, specifically within the specialized niche of drug manufacturing for kidney-related ailments. With a market capitalization..
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a clinical-stage biopharmaceutical company, is capturing investor interest with its innovative approach to treating brain health disorders. With a current market capitalization of $1.46..
Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its focus on rare respiratory diseases. Headquartered in Langhorne, Pennsylvania, Savara’s primary product, molgramostim,..
Avanos Medical, Inc. (NYSE: AVNS), a significant player in the healthcare sector, particularly in the medical devices industry, is a company that demands attention from investors who have an eye..
Cronos Group Inc. (NASDAQ: CRON), a prominent player in the cannabis sector, is drawing attention with its significant revenue growth but faces strategic challenges that warrant a closer look from..
iRadimed Corporation (NASDAQ: IRMD), a prominent player in the medical devices sector, has been capturing investor attention with its strategic focus on MRI-compatible medical devices. As a United States-based company..
AbCellera Biologics Inc. (NASDAQ: ABCL), a prominent player in the biotechnology sector, has been capturing investor attention with a substantial 155.34% potential upside as suggested by analyst ratings. Headquartered in..
